• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.认知障碍中的激越:国际老年精神病学协会临时共识临床与研究定义
Int Psychogeriatr. 2015 Jan;27(1):7-17. doi: 10.1017/S1041610214001963. Epub 2014 Oct 14.
2
Agitation in cognitive disorders: Progress in the International Psychogeriatric Association consensus clinical and research definition.认知障碍中的激越:国际老年精神病学协会共识临床和研究定义的进展。
Int Psychogeriatr. 2024 Apr;36(4):238-250. doi: 10.1017/S1041610222001041. Epub 2023 Mar 7.
3
Defining agitation in the cognitively impaired-a work in progress.界定认知障碍患者的激越——一项正在进行的工作。
Int Psychogeriatr. 2015 Jan;27(1):5-6. doi: 10.1017/S104161021400204X. Epub 2014 Oct 14.
4
Agitation in Cognitive Disorders: Use of the National Alzheimer's Coordinating Center Uniform Data Set (NACC-UDS) to Evaluate International Psychogeriatric Association Definition.认知障碍中的激越:使用国家阿尔茨海默病协调中心统一数据集(NACC-UDS)评估国际老年精神病学协会定义。
Am J Geriatr Psychiatry. 2022 Nov;30(11):1198-1208. doi: 10.1016/j.jagp.2022.03.008. Epub 2022 Apr 21.
5
Longitudinal Course of Agitation and Aggression in Patients with Alzheimer's Disease in a Cohort Study: Methods, Baseline and Longitudinal Results of the A3C Study.队列研究中阿尔茨海默病患者激越和攻击的纵向病程:A3C 研究的方法、基线和纵向结果。
J Prev Alzheimers Dis. 2021;8(2):199-209. doi: 10.14283/jpad.2020.66.
6
The expert consensus guideline series. Treatment of behavioral emergencies 2005.专家共识指南系列。2005年行为紧急情况的治疗
J Psychiatr Pract. 2005 Nov;11 Suppl 1:5-108; quiz 110-2. doi: 10.1097/00131746-200511001-00002.
7
Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus.阿尔茨海默病患者行为和心理症状的管理:国际德尔菲共识。
Int Psychogeriatr. 2019 Jan;31(1):83-90. doi: 10.1017/S1041610218000534. Epub 2018 Aug 2.
8
Co-Occurrence and Predictors of Three Commonly Occurring Behavioral Symptoms in Dementia: Agitation, Aggression, and Rejection of Care.痴呆症中三种常见行为症状的共现情况及预测因素:激越、攻击行为和拒绝护理。
Am J Geriatr Psychiatry. 2017 May;25(5):459-468. doi: 10.1016/j.jagp.2016.10.013. Epub 2016 Nov 3.
9
Use of Actigraphy to Measure Symptoms of Agitation in Dementia.使用活动记录仪测量痴呆症的激越症状。
Am J Geriatr Psychiatry. 2019 Aug;27(8):865-869. doi: 10.1016/j.jagp.2019.02.013. Epub 2019 Feb 27.
10
Association of depression with agitation in elderly nursing home residents.老年疗养院居民中抑郁与激越的关联。
J Geriatr Psychiatry Neurol. 2003 Mar;16(1):4-7. doi: 10.1177/0891988703252157.

引用本文的文献

1
Brexpiprazole for the Treatment of Agitation in Older Adults with Alzheimer's Disease: A Systematic Review, Bayesian Meta-analysis, and Meta-regression.布雷哌唑治疗阿尔茨海默病老年患者的激越:一项系统评价、贝叶斯Meta分析和Meta回归
CNS Drugs. 2025 Aug 31. doi: 10.1007/s40263-025-01219-y.
2
Environmental Triggers of Specific Subtypes of Agitation in People With Dementia: Observational Study.痴呆症患者特定类型激越的环境触发因素:观察性研究。
JMIR Form Res. 2025 Aug 27;9:e60274. doi: 10.2196/60274.
3
Identifying instruments for measuring agitation and other non-cognitive symptoms in people with advanced dementia in residential settings: a scoping review protocol.识别用于测量居住环境中晚期痴呆患者激越及其他非认知症状的工具:一项范围综述方案
BMJ Open. 2025 Aug 12;15(8):e096540. doi: 10.1136/bmjopen-2024-096540.
4
Virtual reality for experiential learning: enhancing agitation management skills, confidence, and empathy in healthcare students.用于体验式学习的虚拟现实:提升医学生的躁动管理技能、自信心和同理心。
Med Educ Online. 2025 Dec;30(1):2542809. doi: 10.1080/10872981.2025.2542809. Epub 2025 Aug 6.
5
Multimodal Detection of Agitation in People With Dementia in Clinical Settings: Observational Pilot Study.临床环境中痴呆患者激越的多模态检测:观察性试点研究。
JMIR Aging. 2025 Jul 15;8:e68156. doi: 10.2196/68156.
6
A New Perspective on Agitation in Alzheimer's Disease: A Potential Paradigm Shift.阿尔茨海默病中激越的新视角:潜在的范式转变
Int J Mol Sci. 2025 Apr 4;26(7):3370. doi: 10.3390/ijms26073370.
7
Updates and future perspectives on neuropsychiatric symptoms in Alzheimer's disease.阿尔茨海默病神经精神症状的最新进展与未来展望
Alzheimers Dement. 2025 Mar;21(3):e70079. doi: 10.1002/alz.70079.
8
Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial.艾司西酞普兰治疗阿尔茨海默病性痴呆激越:一项随机对照3期试验
Nat Med. 2025 May;31(5):1586-1591. doi: 10.1038/s41591-025-03569-y. Epub 2025 Mar 25.
9
Music-based therapeutic interventions for people with dementia.针对痴呆症患者的基于音乐的治疗干预措施。
Cochrane Database Syst Rev. 2025 Mar 7;3(3):CD003477. doi: 10.1002/14651858.CD003477.pub5.
10
An interpretable machine learning tool for in-home monitoring of agitation episodes in people living with dementia: a proof-of-concept study.一种用于居家监测痴呆症患者激越发作的可解释机器学习工具:概念验证研究。
EClinicalMedicine. 2025 Jan 20;80:103032. doi: 10.1016/j.eclinm.2024.103032. eCollection 2025 Feb.

本文引用的文献

1
The impact of neuropsychiatric symptoms on caregiver distress and quality of life in persons with dementia in an Asian tertiary hospital memory clinic.在亚洲一所三级医院的记忆诊所中,神经精神症状对痴呆症患者照顾者的困扰和生活质量的影响。
Int Psychogeriatr. 2013 Dec;25(12):1991-9. doi: 10.1017/S1041610213001518.
2
Activated depression: mixed bipolar disorder or agitated unipolar depression?激活型抑郁:混合性双相障碍还是激越性单相抑郁?
Curr Psychiatry Rep. 2013 Aug;15(8):376. doi: 10.1007/s11920-013-0376-1.
3
Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy.皮质基底节变性和进行性核上性麻痹的神经精神病学。
Int Rev Psychiatry. 2013 Apr;25(2):197-209. doi: 10.3109/09540261.2013.766154.
4
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future.阿尔茨海默病的神经精神症状:过去的进展与未来的展望。
Alzheimers Dement. 2013 Sep;9(5):602-8. doi: 10.1016/j.jalz.2012.12.001. Epub 2013 Apr 3.
5
Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia.肌内注射阿立哌唑用于快速控制双相情感障碍和精神分裂症激越的共识声明。
Curr Med Res Opin. 2013 Mar;29(3):241-50. doi: 10.1185/03007995.2013.766591. Epub 2013 Feb 4.
6
The Sydney Multisite Intervention of LaughterBosses and ElderClowns (SMILE) study: cluster randomised trial of humour therapy in nursing homes.悉尼多中心干预笑声老板和老年小丑(SMILE)研究:养老院幽默疗法的集群随机试验。
BMJ Open. 2013 Jan 11;3(1):e002072. doi: 10.1136/bmjopen-2012-002072.
7
Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease.额眶部-边缘系统萎缩与轻度认知障碍和阿尔茨海默病患者的激越和攻击行为有关。
Alzheimers Dement. 2013 Oct;9(5 Suppl):S95-S104.e1. doi: 10.1016/j.jalz.2012.10.005. Epub 2012 Dec 17.
8
Nonpharmacologic management of behavioral symptoms in dementia.痴呆行为症状的非药物管理。
JAMA. 2012 Nov 21;308(19):2020-9. doi: 10.1001/jama.2012.36918.
9
Diagnosis and management of behavioral issues in frontotemporal dementia.额颞叶痴呆行为问题的诊断与管理。
Curr Neurol Neurosci Rep. 2012 Oct;12(5):528-36. doi: 10.1007/s11910-012-0302-7.
10
Neuropsychiatric symptoms and the risk of institutionalization and death: the aging, demographics, and memory study.神经精神症状与住院和死亡风险:老龄化、人口统计学和记忆研究。
J Am Geriatr Soc. 2011 Mar;59(3):473-81. doi: 10.1111/j.1532-5415.2011.03314.x.

认知障碍中的激越:国际老年精神病学协会临时共识临床与研究定义

Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.

作者信息

Cummings Jeffrey, Mintzer Jacobo, Brodaty Henry, Sano Mary, Banerjee Sube, Devanand D P, Gauthier Serge, Howard Robert, Lanctôt Krista, Lyketsos Constantine G, Peskind Elaine, Porsteinsson Anton P, Reich Edgardo, Sampaio Cristina, Steffens David, Wortmann Marc, Zhong Kate

机构信息

Cleveland Clinic Lou Ruvo Center for Brain Health,Las Vegas,Nevada,USA.

Roper St. Francis Hospital,The Clinical Biotechnology Research Institute,South Carolina,USA.

出版信息

Int Psychogeriatr. 2015 Jan;27(1):7-17. doi: 10.1017/S1041610214001963. Epub 2014 Oct 14.

DOI:10.1017/S1041610214001963
PMID:25311499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4301197/
Abstract

BACKGROUND

Agitation is common across neuropsychiatric disorders and contributes to disability, institutionalization, and diminished quality of life for patients and their caregivers. There is no consensus definition of agitation and no widespread agreement on what elements should be included in the syndrome. The International Psychogeriatric Association formed an Agitation Definition Work Group (ADWG) to develop a provisional consensus definition of agitation in patients with cognitive disorders that can be applied in epidemiologic, non-interventional clinical, pharmacologic, non-pharmacologic interventional, and neurobiological studies. A consensus definition will facilitate communication and cross-study comparison and may have regulatory applications in drug development programs.

METHODS

The ADWG developed a transparent process using a combination of electronic, face-to-face, and survey-based strategies to develop a consensus based on agreement of a majority of participants. Nine-hundred twenty-eight respondents participated in the different phases of the process.

RESULTS

Agitation was defined broadly as: (1) occurring in patients with a cognitive impairment or dementia syndrome; (2) exhibiting behavior consistent with emotional distress; (3) manifesting excessive motor activity, verbal aggression, or physical aggression; and (4) evidencing behaviors that cause excess disability and are not solely attributable to another disorder (psychiatric, medical, or substance-related). A majority of the respondents rated all surveyed elements of the definition as "strongly agree" or "somewhat agree" (68-88% across elements). A majority of the respondents agreed that the definition is appropriate for clinical and research applications.

CONCLUSIONS

A provisional consensus definition of agitation has been developed. This definition can be used to advance interventional and non-interventional research of agitation in patients with cognitive impairment.

摘要

背景

激越在各种神经精神疾病中都很常见,会导致患者及其照料者出现残疾、需要住院治疗,并降低生活质量。目前对于激越尚无共识性定义,对于该综合征应包含哪些要素也未达成广泛共识。国际老年精神医学协会成立了激越定义工作组(ADWG),旨在制定一个适用于认知障碍患者激越的临时共识性定义,该定义可应用于流行病学、非干预性临床、药理学、非药理学干预及神经生物学研究。一个共识性定义将有助于交流和跨研究比较,并且可能在药物研发项目中有监管应用价值。

方法

ADWG采用电子、面对面及基于调查的策略相结合的方式,制定了一个透明的流程,以基于大多数参与者的一致意见达成共识。928名受访者参与了该流程的不同阶段。

结果

激越被广泛定义为:(1)发生于有认知障碍或痴呆综合征的患者;(2)表现出与情绪困扰相符的行为;(3)表现出过度的运动活动、言语攻击或身体攻击;(4)有导致额外残疾且并非完全归因于另一种疾病(精神、医学或物质相关)的行为。大多数受访者对定义中所有调查要素的评价为“强烈同意”或“有些同意”(各要素的同意率为68%-88%)。大多数受访者认为该定义适用于临床和研究应用。

结论

已制定出激越的临时共识性定义。该定义可用于推进对认知障碍患者激越的干预性和非干预性研究。